Eye disease health data study in Germany
Part of Eyes & vision, Heart & circulation clinical trials.
This study looks at health records in Germany to understand how many people have certain eye conditions like age-related macular degeneration, diabetic macular edema, or retinal vein occlusion. It also tests new ways to use this information for research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with one of these eye conditions: wet age-related macular degeneration (nAMD), diabetic macular edema (DME), or retinal vein occlusion (RVO) between January 1, 2009, and December 31, 2024.
- If you have nAMD, you are at least 50 years old.
- If you have DME or RVO, you are at least 18 years old.
- You live in Germany and have statutory or private health insurance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new ways to measure vision and take detailed eye images in people with age-related macular degeneration (AMD), a common eye condition affecting central vision. The goal is to develop better tools for future AMD treatment trials.
This trial uses special eye scans to predict how well anti-VEGF treatment will work for patients with a type of age-related macular degeneration called nAMD. It aims to help doctors better understand who will benefit most from this treatment.
This study observes how diabetes affects vision over time in people with diabetes. It helps doctors better understand eye health without any treatment or intervention.
This study follows people with type 2 diabetes to understand how diabetic retinopathy (an eye disease caused by diabetes) changes over time without treatment. It may help if you have no other eye issues causing new blood vessels and are not planning for certain eye procedures.
This study collects and stores eye (retinal) data to help researchers learn more and improve eye care. You may be able to join if you have diabetes or you are 65 or older.
This study is building a detailed database of images and information from people with various eye diseases, especially those involving inflammation or swelling. Researchers will use advanced cameras and tests to better understand these conditions and potentially improve treatments.
Hear when a new Neovascular Age-related Macular Degeneration (nAMD), Diabetic Macular Edema (DME), Retinal Vein Occlusion (RVO) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.